Cross-pharmacology analysis of G protein-coupled receptors. Academic Article uri icon

start page

  • 1956

end page

  • 1963

abstract

  • The degree of applicability of chemogenomic approaches to protein families depends on the accuracy and completeness of pharmacological data and the corresponding level of pharmacological similarity observed among their protein members. The recent public domain availability of pharmacological data for thousands of small molecules on 204 G protein-coupled receptors (GPCRs) provides a firm basis for an in-depth cross-pharmacology analysis of this superfamily. The number of protein targets included in the cross-pharmacology profile of the different GPCRs changes significantly upon varying the ligand similarity and binding affinity criteria. However, with the exception of muscarinic receptors, aminergic GPCRs distinguish themselves from the rest of the members in the family by their remarkably high levels of pharmacological similarity among them. Clusters of non-GPCR targets related by cross-pharmacology with particular GPCRs are identified and the implications for unwanted side-effects, as well as for repurposing opportunities, discussed.© 2011 Bentham Science Publishers

date/time value

  • 2011

PubMed Identifier

  • 21851335

volume

  • 11

number

  • 15

keywords

  • Databases, Factual
  • Drug Design
  • Drug Discovery
  • Genomics
  • Humans
  • Ligands
  • Pharmacology
  • Receptors, G-Protein-Coupled